HENRY SCHEIN, INC. Proceeds from Sale of Equity Method Investments
HENRY SCHEIN, INC. (HSIC) reported Proceeds from Sale of Equity Method Investments of $0 for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2024-02-28
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for the quarter ending 2022-12-31 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for the quarter ending 2021-12-25 was $0.00, a 100.00% decline year-over-year.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for the quarter ending 2021-09-25 was $10.00M.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for the quarter ending 2021-06-26 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for fiscal 2023 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for fiscal 2021 was $10.00M, a 28.57% decline from fiscal 2020.
- HENRY SCHEIN, INC. proceeds from sale of equity method investments for fiscal 2020 was $14.00M, a 95.44% decline from fiscal 2019.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 3 month as first filed | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 6 month as first filed | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 9 month as first filed | Proceeds from Sale of Equity Method Investments 12 month | Proceeds from Sale of Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-30 | $0.00 10-K · filed 2024-02-28 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||||||
| 2022-09-24 | $0.00 10-Q · filed 2022-11-01 | |||||||
| 2021-12-25 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $10.00M derived: sum of 2 quarters · filed 2024-02-28 | $10.00M derived: sum of 3 quarters · filed 2024-02-28 | $10.00M 10-K · filed 2024-02-28 | $9.76M 10-K · filed 2022-02-15 | |||
| 2021-09-25 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $10.00M derived: sum of 2 quarters · filed 2022-11-01 | $10.00M 10-Q · filed 2022-11-01 | $9.76M 10-Q · filed 2021-11-02 | $12.00M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-26 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | $2.00M derived: sum of 3 quarters · filed 2023-02-21 | $2.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-27 | $0.00 10-Q · filed 2021-05-04 | $2.00M derived: sum of 2 quarters · filed 2023-02-21 | $2.00M derived: sum of 3 quarters · filed 2023-02-21 | $2.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-26 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.00M derived: sum of 2 quarters · filed 2023-02-21 | $2.00M derived: sum of 3 quarters · filed 2023-02-21 | $14.00M 10-K · filed 2023-02-21 | $14.02M 10-K · filed 2021-02-17 | |||
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $12.00M 10-Q · filed 2021-11-02 | $308.75M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $12.00M 10-Q · filed 2021-08-03 | $0.00 10-Q · filed 2020-08-04 | $308.75M derived: sum of 3 quarters · filed 2022-02-15 | $308.75M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-28 | $12.00M 10-Q · filed 2021-05-04 | $0.00 10-Q · filed 2020-05-05 | $308.75M derived: sum of 2 quarters · filed 2022-02-15 | $308.75M derived: sum of 3 quarters · filed 2022-02-15 | $308.75M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2019-12-28 | $296.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $296.75M derived: sum of 2 quarters · filed 2022-02-15 | $296.75M derived: sum of 3 quarters · filed 2022-02-15 | $307.25M 10-K · filed 2022-02-15 | ||||
| 2019-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $10.50M 10-Q · filed 2020-11-02 | $11.50M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $10.50M 10-Q · filed 2020-08-04 | $11.50M derived: sum of 3 quarters · filed 2021-02-17 | $11.50M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-30 | $10.50M 10-Q · filed 2020-05-05 | $11.50M derived: sum of 2 quarters · filed 2021-02-17 | $11.50M derived: sum of 3 quarters · filed 2021-02-17 | $11.50M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-29 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $1.00M derived: sum of 2 quarters · filed 2021-02-17 | $1.00M derived: sum of 3 quarters · filed 2021-02-17 | $1.00M 10-K · filed 2021-02-17 | ||||
| 2018-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||||||
| 2017-12-30 | $34.05M 10-K · filed 2020-02-20 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-20 | |||||||
| 2015-12-26 | $0.00 10-K · filed 2018-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |